Supporting this scenario, previous studies57 demonstrated that intracellular STING signalling and AKT pathways are antagonistically interacted for tumour progression mediated through innate immune responses, while AKTi increases T cell persistency and infiltration as well as early memory phenotype in tumour sites to enhance anti-tumour effect58,59. This evidence concerns the gene STING1 and neoplasm.